Blood pressure targets for the treatment of people with hypertension and cardiovascular disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Blood pressure targets for the treatment of people with hypertension and cardiovascular disease

Published:2020-09-09 Issue:9 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Saiz Luis Carlos¹,Gorricho Javier²,Garjón Javier³,Celaya Mª Concepción⁴,Erviti Juan¹,Leache Leire¹

Affiliation:

1. Unit of Innovation and Organization; Navarre Health Service; Pamplona Spain

2. Planning, Evaluation and Management Service; General Directorate of Health, Government of Navarre; Pamplona Spain

3. Medicines Advice and Information Service; Navarre Health Service; Pamplona Spain

4. Drug Prescribing Service; Navarre Health Service; Pamplona Spain

Publisher

Wiley

Subject

Pharmacology (medical)

Reference109 articles.

1. The rationale and design of the AASK cohort study;Appel;Journal of the American Society of Nephrology,2003

2. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial - correction JAMA 2006 295 23 2726 10.1001/jama.295.23.2726-c

3. Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK);Gassman;Journal of the American Society of Nephrology,2003

4. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) trial;Norris;American Journal of Kidney Diseases,2006

5. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial;Bakris;JAMA,2002

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Multifactorial Relationships: Assessing the Correlation Between Cardiovascular Health Indicators and Metabolic Markers;Cureus;2024-05-08

2. Hohes Risiko für Nebenwirkungen bei Beginn einer antihypertensiven Therapie in vulnerablen Gruppen;Zeitschrift für Allgemeinmedizin;2023-12-21

3. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension;Journal of Hypertension;2023-09-26

4. Cascade forest regression algorithm for non-invasive blood pressure estimation using PPG signals;Applied Soft Computing;2023-09

5. The contribution of mango fruit (Mangifera indica L.) to human nutrition and health;Arabian Journal of Chemistry;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3